MSDL vs ZBH · P/E 15, $1.29B cap vs P/E 23, rev $4.26B
Morgan Stanley Direct Lending Fund (MSDL) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
Morgan Stanley Direct Lending Fund (MSDL) is a asset management company listed on NYSE.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
MSDL does not have a complete income-statement cache yet.
Latest reported ZBH revenue for 2026-06-30 was $4.26B. Net income was $436.5M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
MSDL currently screens at market cap $1.29B and trailing P/E 15.0. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the MSDL and ZBH stock pages for the full models.
Not investment advice.